FDA approves updated Covid-19 vaccines

Live updates

1. 1h ago

   FDA approves 2026-2027 COVID-19 vaccines targeting XFG variant

   The FDA has approved updated COVID-19 vaccines for the 2026-2027 season to target the dominant XFG variant. Approved products include Spikevax and mNEXSPIKE from Moderna, Nuvaxovid from Sanofi, and formulations from Pfizer-BioNTech. Current approvals focus on adults 65 and older and those with underlying health conditions. While case numbers are climbing in areas like Kansas City and Bexar County, they remain below levels seen in previous years. Mayo Clinic issued guidance on August 28 regarding who should receive the updated doses this fall.

   Why it matters

   These updates coincide with students returning to school, a period that typically triggers surges in respiratory infections. The XFG Stratus variant is the primary target for this season's formulations. Manufacturers are distributing doses to pharmacies and hospitals as regional case trends shift.

   What is confirmed

   • The FDA approved updated COVID-19 vaccines for the 2026-2027 season targeting the XFG variant.
   • Approved vaccines include products from Moderna, Pfizer-BioNTech, and Sanofi.
   • Mayo Clinic issued guidance on August 28 regarding the updated fall vaccine.

   Still unconfirmed

   • The FDA released Pfizer from commitments made during its last COVID vaccine approval.
   • Moderna stock rose 156% in August.

   What to watch next

   • Clarification on insurance coverage for low-risk individuals
   • Clinical trial results for Invivyd's VYD2311 studies
   • Updated case numbers as school attendance increases nationwide
   Sources used for this update (7)

   1. medicaldialogues.in — FDA Approves Updated COVID-19 Vaccines Targeting XFG Variant for 2026–2027
   2. www.kcur.org — As Kansas City kids go back to school, here's what to know about disease and vaccines
   3. www.yahoo.com — Mayo Clinic releases guidance for this year's COVID-19 vaccine
   4. www.usatoday.com — While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 ...
   5. www.insidermonkey.com — Moderna (MRNA) Soars 156% in August — Here’s What Propelled The Rally
   6. justthenews.com — From 'measles-associated' deaths to new COVID vaccines, doubts mount based on absence of evidence
   7. markets.businessinsider.com — Invivyd Appoints Chairman Marc W. Elia as Chief Executive Officer; Approaches Results of VYD2311 studies DECLARATION and LIBERTY
   confidence 90%
2. 2d ago

   FDA Approves Updated COVID-19 Vaccines for 2026-27 Season

   The FDA approved updated COVID-19 vaccines from Moderna, Pfizer-BioNTech, and Novavax-Sanofi to combat the XFG Stratus variant. Moderna's approved products include Spikevax and mNEXSPIKE, while Sanofi's approved vaccine is Nuvaxovid. Current approvals target adults 65 and older and individuals with underlying health conditions. These approvals come as COVID-19 cases rise in areas like Bexar County, coinciding with students returning to school. Manufacturers are shipping doses to hospitals and pharmacies, though insurance coverage for low-risk individuals remains uncertain.

   Why it matters

   The XFG Stratus variant is the current dominant strain driving a new wave of infections. This seasonal update follows a pattern of tailoring mRNA and protein-based vaccines to evolving subvariants. The timing aligns with a broader increase in respiratory illnesses as autumn begins.

   What is confirmed

   • The FDA approved updated COVID-19 vaccines from Moderna, Pfizer-BioNTech, and Novavax-Sanofi for the 2026-27 season.
   • Moderna's approved vaccines include Spikevax and mNEXSPIKE.
   • Sanofi's approved vaccine is Nuvaxovid.
   • Approvals cover adults aged 65 and older and younger people with underlying health conditions.
   • The vaccines target the XFG Stratus variant.

   Still unconfirmed

   • Insurance coverage for people not in high-risk categories is currently uncertain.
   • Bexar County hospitals are seeing more COVID-19 cases as students return to classrooms.

   What to watch next

   • Confirmation of insurance coverage for healthy adults under 65
   • Distribution timelines for pharmacies and hospitals
   Sources used for this update (5)

   1. www.ad-hoc-news.de — Resilient Sanofi stock rides FDA approval of updated COVID vaccine
   2. www.straitstimes.com — Success after a century of failures: Inside Moderna and Merck’s cancer vaccine breakthrough
   3. www.ad-hoc-news.de — BioNTech's Monotherapy Setback Puts Platform Strategy in the Spotlight
   4. www.ksat.com — COVID-19 is back on the rise in Bexar County. Here's what you need to know.
   5. uk.finance.yahoo.com — What Do Moderna (MRNA) FDA Vaccine Approvals Mean For Its Respiratory Push?
   confidence 90%
3. 3d ago

   FDA approves updated Covid-19 vaccines for 2026-27 season

   The FDA has approved updated Covid-19 vaccines from Moderna, Pfizer-BioNTech, and Novavax-Sanofi for the 2026-27 season to target the dominant XFG Stratus variant. The decision allows manufacturers to begin shipping doses, which are expected to arrive at pharmacies and hospitals within days. Current approvals specifically cover adults aged 65 and older and younger individuals with underlying health conditions. While the shots target the latest strain as cases rise, uncertainty remains regarding insurance coverage for those who do not fall into these high-risk categories.

   Why it matters

   These updates align with the annual cycle of adjusting vaccine formulas to match circulating strains of the virus. The XFG variant has become the dominant strain, necessitating a revised formula to maintain efficacy. This rollout occurs amid a reported increase in Covid-19 cases.

   What is confirmed

   • The FDA approved updated Covid-19 vaccines for the 2026-27 season.
   • The updated vaccines target the dominant XFG variant, also referred to as Stratus.
   • Approved manufacturers include Moderna, Pfizer-BioNTech, and Novavax-Sanofi.
   • Moderna received approval for updated Spikevax and mNEXSPIKE formulas on August 27, 2026.

   Still unconfirmed

   • Doses are approved for adults 65 and older and younger people with underlying conditions, but insurance coverage for others is unclear.

   What to watch next

   • Clarification on insurance coverage for healthy adults under 65
   • Official rollout dates for pharmacy and hospital distribution
   Sources used for this update (15)

   1. The New York Times — What to Know About New Covid Vaccines for Fall 2026
   2. The Washington Post — FDA just approved updated covid shots. Here’s what to know as cases rise.
   3. Reuters — US FDA approves updated COVID vaccines for 2026-27 season
   4. CNN — FDA approves updated Covid-19 vaccines
   5. KATU — FDA approves updated COVID-19 vaccines from Pfizer & Moderna, companies say
   6. The Guardian — FDA approves updated Covid-19 vaccines for dominant XFG variant
   7. www.yahoo.com — The FDA just approved this year’s Covid vaccines - here’s what you need to know about the shots
   8. abcnews.com — FDA approves updated COVID vaccines. Here's what you need to know
   9. finance.yahoo.com — Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
   10. www.deseret.com — Updated COVID shots are approved. Getting one may not be simple
   11. www.theguardian.com — FDA approves updated Covid-19 vaccines for dominant XFG variant
   12. www.aol.com — Everything you need to know about updated COVID vaccines following FDA approval
   confidence 95%